Valsartan/hydrochlorothiazide
Valsartan/hydrochlorothiazide, sold under the trade name Co-Diovan among others, is an medication used to treat high blood pressure when valsartan is not sufficient.[1] It is a combination of valsartan, an angiotensin receptor blocker with hydrochlorothiazide, a diuretic.[2] It is taken by mouth.[2]
| Combination of | |
|---|---|
| Valsartan | Angiotensin II receptor antagonist |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| Trade names | Co-vasotec, Diovan HCT, Co-Diovan, others |
| AHFS/Drugs.com | FDA Professional Drug Information |
| MedlinePlus | a611032 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| PubChem CID | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| (verify) | |
Common side effects include dizziness and headaches.[2] Serious side effects may include allergic reactions, electrolyte abnormalities, and glaucoma.[3] Use in pregnancy is not recommended.[3]
The combination was approved for medical use in the United States in 1998.[2] It is available as a generic medication.[1] A month supply in the United Kingdom costs the NHS about 1.85 as of 2019.[1] In the United States the wholesale cost of this amount is about US$4.40.[4] In 2016 it was the 134th most prescribed medication in the United States with more than 5 million prescriptions.[5]
References
- British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 179. ISBN 9780857113382.
- "Hydrochlorothiazide and valsartan Uses, Side Effects & Warnings". Drugs.com. Retrieved 10 March 2019.
- "Valsartan and Hydrochlorothiazide - FDA prescribing information, side effects and uses". Drugs.com. Retrieved 10 March 2019.
- "NADAC as of 2019-02-27". Centers for Medicare and Medicaid Services. Retrieved 3 March 2019.
- "The Top 300 of 2019". clincalc.com. Retrieved 22 December 2018.